235 related articles for article (PubMed ID: 25880145)
1. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart.
Surinkaew S; Kumphune S; Chattipakorn S; Chattipakorn N
J Cardiovasc Pharmacol; 2013 Feb; 61(2):133-41. PubMed ID: 23107875
[TBL] [Abstract][Full Text] [Related]
3. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
4. Analyzing the anti-ischemia-reperfusion injury effects of ginsenoside Rb1 mediated through the inhibition of p38α MAPK.
Li G; Qian W; Zhao C
Can J Physiol Pharmacol; 2016 Jan; 94(1):97-103. PubMed ID: 26550918
[TBL] [Abstract][Full Text] [Related]
5. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion.
Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H
Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421
[TBL] [Abstract][Full Text] [Related]
6. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes.
Engelbrecht AM; Niesler C; Page C; Lochner A
Basic Res Cardiol; 2004 Sep; 99(5):338-50. PubMed ID: 15309413
[TBL] [Abstract][Full Text] [Related]
7. Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection.
Gao XF; Zhou Y; Wang DY; Lew KS; Richards AM; Wang P
Mol Cell Biochem; 2015 Jan; 398(1-2):135-46. PubMed ID: 25245818
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 mitogen-activated protein kinase may decrease intestinal epithelial cell apoptosis and improve intestinal epithelial barrier function after ischemia- reperfusion injury.
Zheng SY; Fu XB; Xu JG; Zhao JY; Sun TZ; Chen W
World J Gastroenterol; 2005 Feb; 11(5):656-60. PubMed ID: 15655816
[TBL] [Abstract][Full Text] [Related]
9. Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo.
Wang J; Yang H; Hu X; Fu W; Xie J; Zhou X; Xu W; Jiang H
J Surg Res; 2013 Aug; 183(2):509-16. PubMed ID: 23531454
[TBL] [Abstract][Full Text] [Related]
10. Ferulic Acid Administered at Various Time Points Protects against Cerebral Infarction by Activating p38 MAPK/p90RSK/CREB/Bcl-2 Anti-Apoptotic Signaling in the Subacute Phase of Cerebral Ischemia-Reperfusion Injury in Rats.
Cheng CY; Tang NY; Kao ST; Hsieh CL
PLoS One; 2016; 11(5):e0155748. PubMed ID: 27187745
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
Barancik M; Htun P; Strohm C; Kilian S; Schaper W
J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
[TBL] [Abstract][Full Text] [Related]
12. The p38 MAPK inhibitor SB203580 blocks adenosine A(1) receptor-induced attenuation of in vivo myocardial stunning.
Yoshimura Y; Kristo G; Keith BJ; Jahania SA; Mentzer RM; Lasley RD
Cardiovasc Drugs Ther; 2004 Nov; 18(6):433-40. PubMed ID: 15770430
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL
Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization.
Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1107-14. PubMed ID: 17496214
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
Yu D; Li M; Tian Y; Liu J; Shang J
Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
[TBL] [Abstract][Full Text] [Related]
16. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
17. Ischemic preconditioning or p38 MAP kinase inhibition attenuates myocardial TNF alpha production and mitochondria damage in brief myocardial ischemia.
Kimura H; Shintani-Ishida K; Nakajima M; Liu S; Matsumoto K; Yoshida K
Life Sci; 2006 Mar; 78(17):1901-10. PubMed ID: 16497338
[TBL] [Abstract][Full Text] [Related]
18. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
19. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
